ライフサイエンスコーパス: tartrate-resistant acid phosphatase

1 orrelated with expression of the target gene tartrate-resistant acid phosphatase.

2 ent decrease in secretion of cathepsin B and tartrate-resistant acid phosphatase.

3 The number of osteoclasts was determined by tartrate-resistant acid phosphatase.

4 ors including NFAT2, TRAF6, cathepsin K, and tartrate-resistant acid phosphatase.

5 lcin, bone-specific alkaline phosphatase, or tartrate-resistant acid phosphatase.

6 ) were stained with hematoxylin and eosin or tartrate-resistant acid phosphatase.

7 sections stained with hematoxylin-eosin and tartrate-resistant acid phosphatase.

8 -cells, c1 (NFATc1), cathepsin K (Cstk), and tartrate-resistant acid phosphatase 5 (TRAP) with recept

9 unting of the in vivo bone resorption marker tartrate-resistant acid phosphatase 5b (TRACP 5b).

10 serum bone alkaline phosphatase (B-ALP) and tartrate-resistant acid phosphatase 5b (TRAP-5b), and ca

11 this was accompanied by an increase in serum Tartrate-resistant acid phosphatase 5b (TRAP5b) levels.

12 Even though tartrate-resistant acid phosphatase 5b was expressed, pr

13 rocollagen type-1 N-terminal propeptide, and tartrate-resistant acid phosphatase 5b were associated w

14 elopeptide of type I collagen) and TRACP-5b (tartrate-resistant acid phosphatase 5b).

15 procollagen type-1 N-terminal propeptide, or tartrate-resistant acid phosphatase 5b; these values cor

16 Serum levels of human OPG-Fc and tartrate-resistant acid phosphatase-5b (TRAP-5b) were me

17 xpress the purple, band 5 isozyme (Acp 5) of tartrate-resistant acid phosphatase, a binuclear metallo

18 ophospholipase A, and tartrate-sensitive and tartrate-resistant acid phosphatase activities and influ

19 d by analyses for calcium release or uptake, tartrate-resistant acid phosphatase activity (marker for

20 eveal a previously unrecognized link between tartrate-resistant acid phosphatase activity and interfe

21 nto osteoclasts was assessed by staining for tartrate-resistant acid phosphatase activity.

22 xacin; V-ATPase, vacuolar H(+)-ATPase; TRAP, tartrate-resistant acid phosphatase; alphaMEM D10, minim

23 factor I concentrations and increased serum tartrate-resistant acid phosphatase and 25-hydroxyvitami

24 ive induction of OCL-specific genes, such as tartrate-resistant acid phosphatase and immunoreceptor O

25 Tartrate-resistant acid phosphatase and osteocalcin were

26 e, multinucleated osteoclasts that expressed tartrate-resistant acid phosphatase and were capable of

27 ing matrix metalloproteinase 9, cathepsin K, tartrate-resistant acid phosphatase, and carbonic anhydr

28 ure, downregulation of the HCL markers CD25, tartrate-resistant acid phosphatase, and cyclin D1, smoo

29 OCs, including multinucleation, presence of tartrate-resistant acid phosphatase, and expression of t

30 m the center of the lesion, were stained for tartrate-resistant acid phosphatase, and histomorphometr

31 ls, expression of receptors for AGEs (RAGE), tartrate-resistant acid phosphatase, and proliferating c

32 expression of the receptor for AGEs (RAGE), tartrate-resistant acid phosphatase, and proliferating c

33 line phosphatase, bone alkaline phosphatase, tartrate-resistant acid phosphatase, and urinary cross-l

34 nduce osteoclast formation was determined by tartrate resistant acid phosphatase assay.

35 sed by enzyme-linked immunosorbent assay and tartrate-resistant acid phosphatase assay.

36 gulate calcitonin receptor, but they express tartrate-resistant acid phosphatase, cathepsin K, and be

37 ophathalmia-associated transcription factor, tartrate-resistant acid phosphatase, cathepsin K, and be

38 urface membrane phospho-monoesterase, i.e. a tartrate-resistant acid phosphatase (Cl MAcP) was also f

39 enerated with a transgenic construct using a tartrate-resistant acid phosphatase exon 1C promoter to

40 could collaborate with MITF to activate the tartrate-resistant acid phosphatase gene promoter depend

41 lammation were assessed by histomorphometry, tartrate-resistant acid phosphatase histoenzymology, and

42 Sequencing of ACP5, encoding tartrate-resistant acid phosphatase, identified bialleli

43 eptor type 4, nuclear factor kappa beta, and tartrate-resistant acid phosphatase immunostaining.

44 iding cells expressing the osteoclast marker tartrate resistant acid phosphatase, in vivo.

45 vely expresses a unique externally oriented, tartrate-resistant, acid phosphatase on its surface memb

46 Osteoclast morphology was analyzed in tartrate-resistant acid phosphatase or F-actin-stained s

47 crophage marker CD11b, the osteoclast marker tartrate-resistant acid phosphatase, or carbonic anhydra

48 proximately 5% of the mononuclear cells were tartrate-resistant acid phosphatase positive, and these

49 specimens contained MNCs that were intensely tartrate-resistant acid phosphatase positive; approximat

50 TRAP (tartrate-resistant acid phosphatase)-positive osteoclast

51 ssenger RNA and protein, along with elevated tartrate-resistant acid phosphatase-positive (TRAP+) OCs

52 ha tumors associated with significantly more tartrate-resistant acid phosphatase-positive (TRAP+) ost

53 ns, serum interleukin (IL)-1beta levels, and tartrate-resistant acid phosphatase-positive (TRAP+) ost

54 y features of the osteoclast: multinucleated tartrate-resistant acid phosphatase-positive cell format

55 lasts as the number of pits produced by each tartrate-resistant acid phosphatase-positive cell is red

56 Mice with depletion of PDGF-BB in the tartrate-resistant acid phosphatase-positive cell lineag

57 The number of multinucleated tartrate-resistant acid phosphatase-positive cells along

58 wer maturation into osteoclasts with reduced tartrate-resistant acid phosphatase-positive cells and d

59 These multinucleated, tartrate-resistant acid phosphatase-positive cells were

60 ion and maintenance of large multinucleated, tartrate-resistant acid phosphatase-positive cells.

61 cent to and distal from pannus invasion, and tartrate-resistant acid phosphatase-positive multinuclea

62 (C453S) significantly enhanced the number of tartrate-resistant acid phosphatase-positive multinuclea

63 GM1 with primary bone marrow cells generated tartrate-resistant acid phosphatase-positive multinuclea

64 No tartrate-resistant acid phosphatase-positive multinuclea

65 ion were evaluated by counting the number of tartrate-resistant acid phosphatase-positive multinuclea

66 x metalloproteinase 9, and the generation of tartrate-resistant acid phosphatase-positive multinuclea

67 egenerative cell lines reduced the number of tartrate-resistant acid phosphatase-positive osteoclast-

68 teoclast cell fusion, forming multinucleated tartrate-resistant acid phosphatase-positive osteoclast-

69 yelomonocytic precursors into multinucleated tartrate-resistant acid phosphatase-positive osteoclasts

70 The number of tartrate-resistant acid phosphatase-positive osteoclasts

71 ysis was characterized by reduced numbers of tartrate-resistant acid phosphatase-positive osteoclasts

72 Catabolic activity was analyzed with tartrate-resistant acid phosphatase-positive osteoclasts

73 ells in vitro, as evidenced by a decrease in tartrate-resistant acid phosphatase-positive osteoclasts

74 or induction of bone marrow macrophages into tartrate-resistant acid phosphatase-positive preosteocla

75 -29b, or -29c diminished formation of TRAP (tartrate-resistant acid phosphatase-positive) multinucle

76 eated with aPDT exhibited reduced numbers of tartrate-resistant acid-phosphatase-positive cells and m

77 We used the tartrate-resistant acid phosphatase promoter to target t

78 Tartrate-resistant acid phosphatase reaction and immunoh

79 A parallel series of tartrate resistant acid phosphatase-stained sections wer

80 Osteoclasts were counted in tartrate-resistant acid phosphatase-stained sections.

81 and function were assessed via quantitative tartrate-resistant acid phosphatase staining and degrada

82 Tartrate-resistant acid phosphatase staining demonstrate

83 Mmp-2, and Mmp-14 were expressed widely, and tartrate-resistant acid phosphatase staining notably was

84 ysis, microcomputed tomography analysis, and tartrate-resistant acid phosphatase staining revealed re

85 Tartrate-resistant acid phosphatase staining was used to

86 leated giant cells with varying intensity of tartrate-resistant acid phosphatase staining were regula

87 H&E and tartrate-resistant acid phosphatase staining were used t

88 human preosteoclastic cells was assessed by tartrate-resistant acid phosphatase staining, whereas th

89 ated osteoclastic cells was determined after tartrate-resistant acid phosphatase staining.

90 al fluid (SF) macrophages were determined by tartrate-resistant acid phosphatase staining.

91 hemistry, and osteoclasts were enumerated by tartrate-resistant acid phosphatase staining.

92 PBMC differentiation to OCs was confirmed by tartrate-resistant acid phosphatase staining; bone resor

93 mouse tails, using hematoxylin and eosin and tartrate-resistant acid phosphatase to confirm the prese

94 Meanwhile, CLA significantly reduced femur tartrate resistant acid phosphatase (TRAP) activity, sug

95 Hemin inhibits transcription of the tartrate resistant acid phosphatase (TRAP) gene.

96 en c-src proto-oncogene from the promoter of tartrate resistant acid phosphatase (TRAP), a gene that

97 stal side of the molars until 6 months using tartrate resistant acid phosphatase (TRAP).

98 The enzyme tartrate resistant acid phosphatase (TRAP, two isoforms

99 ic differentiation as evidenced by increased tartrate-resistant acid phosphatase (TRAP) activity and

100 However, the absence of tartrate-resistant acid phosphatase (TRAP) activity and

101 the number of multinuclear cells expressing tartrate-resistant acid phosphatase (TRAP) activity prod

102 The inhibition of osteoclastogenesis and tartrate-resistant acid phosphatase (TRAP) activity was

103 ounterparts they are larger, fail to express tartrate-resistant acid phosphatase (TRAP) activity, and

104 e colocalization of messenger RNA (mRNA) for tartrate-resistant acid phosphatase (TRAP) and cathepsin

105 toplasmic, calcineurin-dependent 1 (NFATc1), tartrate-resistant acid phosphatase (TRAP) and cathepsin

106 ere performed on media and cell lysates, and tartrate-resistant acid phosphatase (TRAP) and mRNA dete

107 Serial sections were reacted for tartrate-resistant acid phosphatase (TRAP) and nonspecif

108 -dihydroxycholecalciferol and coincided with tartrate-resistant acid phosphatase (TRAP) expression, a

109 d alkaline phosphatase (AP) for osteoblasts; tartrate-resistant acid phosphatase (TRAP) for osteoclas

110 ast differentiation, plays a pivotal role in tartrate-resistant acid phosphatase (TRAP) gene expressi

111 a novel CD gene regulated by the osteoclast tartrate-resistant acid phosphatase (TRAP) gene promoter

112 e sialoprotein (BSP), osteocalcin (OCN), and tartrate-resistant acid phosphatase (TRAP) immunohistoch

113 IL-4 down-regulates expression of tartrate-resistant acid phosphatase (TRAP) in mature ost

114 ecessary for activation of target genes like tartrate-resistant acid phosphatase (TRAP) in osteoclast

115 Tartrate-resistant acid phosphatase (TRAP) is an iron-co

116 The tartrate-resistant acid phosphatase (TRAP) is present in

117 d hematoxylin and eosin and subjected to the tartrate-resistant acid phosphatase (TRAP) method.

118 These MNCs were also positive for tartrate-resistant acid phosphatase (TRAP) mRNA and TRAP

119 Tartrate-resistant acid phosphatase (TRAP) plays an impo

120 Tartrate-resistant acid phosphatase (TRAP) staining show

121 was analyzed by immunohistochemistry, using tartrate-resistant acid phosphatase (TRAP) staining to i

122 Tartrate-resistant acid phosphatase (TRAP) staining, res

123 nalysis and immunohistochemical detection of tartrate-resistant acid phosphatase (TRAP) were also per

124 B ligand (RANKL), osteoprotegerin (OPG), and tartrate-resistant acid phosphatase (TRAP) were assessed

125 Histological sections stained for tartrate-resistant acid phosphatase (TRAP) were quantifi

126 a strongly reduced formation of multinuclear tartrate-resistant acid phosphatase (TRAP)(+) osteoclast

127 appaB ligand (RANKL), osteoprotegerin (OPG), tartrate-resistant acid phosphatase (TRAP), and activate

128 eptor activator of NK-kappaB ligand (RANKL), tartrate-resistant acid phosphatase (TRAP), and osteocla

129 ocollagen I carboxy-terminal propeptide, and tartrate-resistant acid phosphatase (TRAP), and urinary

130 on of matrix metallopeptidase 13 (MMP13) and tartrate-resistant acid phosphatase (TRAP), leading to a

131 Cells were fixed and stained for tartrate-resistant acid phosphatase (TRAP), Oregon Green

132 BL, TBA, the positive cells for tartrate-resistant acid phosphatase (TRAP), receptor act

133 significant elevation of the active form of tartrate-resistant acid phosphatase (TRAP)-5b.

134 sence of IL-4, we detected the appearance of tartrate-resistant acid phosphatase (TRAP)-negative mult

135 counted as bone-associated multi-nucleated, tartrate-resistant acid phosphatase (TRAP)-positive cell

136 nificantly lower level of bone loss and less tartrate-resistant acid phosphatase (TRAP)-positive cell

137 igature-induced bone loss in mice with fewer tartrate-resistant acid phosphatase (TRAP)-positive cell

138 confirmed the decreased bone mass, increased tartrate-resistant acid phosphatase (TRAP)-positive cell

139 NF-kappaB ligand formation of multinucleated tartrate-resistant acid phosphatase (TRAP)-positive cell

140 st/periodontal ligament cells displayed more tartrate-resistant acid phosphatase (TRAP)-positive cell

141 Tartrate-resistant acid phosphatase (TRAP)-positive oste

142 matoxylin and eosin, immunohistochemical, or tartrate-resistant acid phosphatase (TRAP)-stained secti

143 ltinucleated cells that stained positive for tartrate-resistant acid phosphatase (TRAP).

144 B ligand (RANKL), osteoprotegerin (OPG), and tartrate-resistant acid phosphatase (TRAP).

145 otegerin expression, and a decrease in serum tartrate-resistant acid phosphatase (TRAP5b) concentrati

146 Tartrate-resistant acid phosphatase (type V) (TRAP) was

147 of nuclear factor-kappaB ligand (RANKL) and tartrate resistant acid phosphatase were significantly d

148 received Scl-AbI, although levels of type 5b tartrate-resistant acid phosphatase were significantly l